Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. JW (Cayman) Therapeutics Co. Ltd
  6. News
  7. Summary
    2126   KYG5210T1040

JW (CAYMAN) THERAPEUTICS CO. LTD

(2126)
  Report
End-of-day quote. End-of-day quote Hong Kong Stock Exchange - 01/26
10.16 HKD   -2.68%
01/10JW Therapeutics Appoints Immunotherapy Expert as Chief Scientific Officer
MT
01/09JW Therapeutics Announces Management Appointments
CI
2021JW Therapeutics Grants Share Options to Certain Employees
MT
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

JW Therapeutics Co. Ltd Announces Board and Committee Changes

12/03/2021 | 07:55am EST

The board of directors of JW (Cayman) Therapeutics Co. Ltd. (the "Company", together with its subsidiaries, the "Group") announced the changes to the Board and the composition of the Board committees. The board announced that, with effect from December 3, 2021, (i) Mr. Hans Edgar Bishop ("Mr. Bishop") has resigned as a non-executive Director and a member of the remuneration committee of the Company (the "Remuneration Committee"); and (ii) Mr. Yanling Cao ("Mr. Cao") has resigned as an independent non-executive Director and a member of the nomination committee of the Company (the "Nomination Committee"), due to their decisions to devote more time to their other commitments. Mr. Bishop will remain with the Company as a senior advisor. The Board further announced that, with effect from December 3, 2021, (i) Dr. Ann Li Lee, a non-executive Director, has been appointed as a member of the Remuneration Committee; and (ii) Mr. Kin Cheong Kelvin Ho, an independent non-executive Director, has been appointed as a member of the Nomination Committee.


© S&P Capital IQ 2021
All news about JW (CAYMAN) THERAPEUTICS CO. LTD
01/10JW Therapeutics Appoints Immunotherapy Expert as Chief Scientific Officer
MT
01/09JW Therapeutics Announces Management Appointments
CI
2021JW Therapeutics Grants Share Options to Certain Employees
MT
2021JW Therapeutics Co. Ltd Announces Executive Changes
CI
2021JW Therapeutics Presents Immunotherapy Study Findings at US Conference; Shares Jump 4%
MT
2021JW Therapeutics Co. Ltd Announces Board and Committee Changes
CI
2021JW CAYMAN THERAPEUTICS : Therapeutics Awards 7 Million Share Options, Nearly 5 Million Res..
MT
2021JW (CAYMAN) THERAPEUTICS : to Start Clinical Trials of Multiple Myeloma Treatment in China
MT
2021JW Therapeutics Announces IND Approval for the Clinical Trial of JWCAR129
CI
2021JW CAYMAN THERAPEUTICS : Therapeutics Says Immunotherapy Shows Long-Term Efficacy in Large..
MT
More news
Financials
Sales 2021 57,5 M 9,09 M 9,09 M
Net income 2021 -603 M -95,4 M -95,4 M
Net cash 2021 1 836 M 290 M 290 M
P/E ratio 2021 -5,87x
Yield 2021 -
Capitalization 3 361 M 532 M 532 M
EV / Sales 2021 26,5x
EV / Sales 2022 7,13x
Nbr of Employees 477
Free-Float -
Chart JW (CAYMAN) THERAPEUTICS CO. LTD
Duration : Period :
JW (Cayman) Therapeutics Co. Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JW (CAYMAN) THERAPEUTICS CO. LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 8,25 CNY
Average target price 20,67 CNY
Spread / Average Target 151%
EPS Revisions
Managers and Directors
Yi Ping Li Chairman & Chief Executive Officer
Xin Fu Chief Financial Officer & Senior Vice President
Lapyuen Harry Lam Chief Technology Officer & Executive VP
Shaun Paul Cordoba Chief Scientific Officer
Chi Shing Li Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
JW (CAYMAN) THERAPEUTICS CO. LTD-24.40%547
GILEAD SCIENCES, INC.-5.19%86 352
REGENERON PHARMACEUTICALS-4.49%63 067
VERTEX PHARMACEUTICALS3.42%57 743
WUXI APPTEC CO., LTD.-12.11%50 700
BIONTECH SE-39.30%37 796